Treatment Development of Triheptanoin (G1D)

Clinical trial NCT03041363 · COMPLETED

Trial details

NCT number: NCT03041363
Sponsor: Juan Pascual
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epilepsy GLUT1DS1 Glut1 Deficiency Syndrome 1, Autosomal Recessive Glucose Metabolism Disorders Glucose Transport Defect Glucose Transporter Type 1 Deficiency Syndrome Glucose Transporter Protein Type 1 Deficiency Syndrome

Start date: 2017-03-29
Primary completion: 2017-12-22
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.